scispace - formally typeset
Open AccessJournal Article

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

TLDR
The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) as discussed by the authors is an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses.
About
This article is published in Revista Española de Nutrición Humana y Dietética.The article was published on 2014-01-01 and is currently open access. It has received 4567 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

TL;DR: A reporting guideline is described, the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P 2015), which consists of a 17-item checklist intended to facilitate the preparation and reporting of a robust protocol for the systematic review.
Journal ArticleDOI

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

TL;DR: The PRISMA-P checklist as mentioned in this paper provides 17 items considered to be essential and minimum components of a systematic review or meta-analysis protocol, as well as a model example from an existing published protocol.
Journal ArticleDOI

The Effect of Riding as an Alternative Treatment for Children with Cerebral Palsy: A Systematic Review and Meta-Analysis

TL;DR: HT, THR, and AS seem to improve the total score of the gross motor function via improvement of the walking, running, and jumping dimension, however, they are not likely to be of benefit to the symmetry of postural muscle activity.
Journal ArticleDOI

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

TL;DR: The results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain and allow a strong recommendation for use and proposal as first-line treatment in neuropathicPain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin.
Related Papers (5)